PMC:7195088 / 50385-50593 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1508","span":{"begin":47,"end":55},"obj":"Species"},{"id":"1509","span":{"begin":173,"end":181},"obj":"Species"},{"id":"1517","span":{"begin":69,"end":87},"obj":"Chemical"},{"id":"1527","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"1528","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A1508","pred":"tao:has_database_id","subj":"1508","obj":"Tax:9606"},{"id":"A1509","pred":"tao:has_database_id","subj":"1509","obj":"Tax:9606"},{"id":"A1517","pred":"tao:has_database_id","subj":"1517","obj":"MESH:D006886"},{"id":"A1527","pred":"tao:has_database_id","subj":"1527","obj":"MESH:C000657245"},{"id":"A1528","pred":"tao:has_database_id","subj":"1528","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"all controlled nonrandomized study of COVID-19 patients treated with hydroxychloroquine has been recently published [41]. In this study, Gautret et al. enrolled 26 COVID-19 patients to receive 200 mg of hydro"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T275","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"T276","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A275","pred":"mondo_id","subj":"T275","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A276","pred":"mondo_id","subj":"T276","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"all controlled nonrandomized study of COVID-19 patients treated with hydroxychloroquine has been recently published [41]. In this study, Gautret et al. enrolled 26 COVID-19 patients to receive 200 mg of hydro"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T291","span":{"begin":88,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T292","span":{"begin":117,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"all controlled nonrandomized study of COVID-19 patients treated with hydroxychloroquine has been recently published [41]. In this study, Gautret et al. enrolled 26 COVID-19 patients to receive 200 mg of hydro"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43255","span":{"begin":69,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A59547","pred":"chebi_id","subj":"T43255","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"all controlled nonrandomized study of COVID-19 patients treated with hydroxychloroquine has been recently published [41]. In this study, Gautret et al. enrolled 26 COVID-19 patients to receive 200 mg of hydro"}